CORRELATING RATIOS OF AMINES IN PLASMA AND CEREBROSPINAL FLUID 73 3 21. Westergren I, Nyström B, Hamberger A, Nordborg C, Johansson BB. Concentrations of amino acids in extracellular fluid after opening of the blood-brain barrier by intracarotid infusion of protamine sulfate. J Neurochem. 1994;62(1):159-165. 22. O’Kane RL, Hawkins RA. Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the bloodbrain barrier. Am J Physiol Endocrinol Metab. 2003;285(6):E1167-1173. 23. del Amo EM, Urtti A, Yliperttula M. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur J Pharm Sci. 2008;35(3):161-174. 24. Hawkins RA, O’Kane RL, Simpson IA, Vina JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr. 2006;136(1 Suppl):218S-226S. 25. Schweikhard ES, Ziegler CM. Amino acid secondary transporters: toward a common transport mechanism. Curr Top Membr. 2012;70:1-28. 26. Nałęcz KA. Solute Carriers in the Blood-Brain Barier: Safety in Abundance. Neurochem Res. 2017;42(3):795-809. 27. Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A. 1999;96(21):12079-12084. 28. Poncet N, Mitchell FE, Ibrahim AF, et al. The catalytic subunit of the system L1 amino acid transporter (slc7a5) facilitates nutrient signalling in mouse skeletal muscle. PLoS One. 2014;9(2):e89547. 29. Zaragozá R. Transport of Amino Acids Across the Blood-Brain Barrier. Front Physiol. 2020;11:973-973. 30. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science. 1972;178(4059):414-416. 31. O’Kane RL, Vina JR, Simpson I, et al. Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+. Am J Physiol Endocrinol Metab. 2006;291(2):E412419. 32. McDonald KK, Zharikov S, Block ER, Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the “arginine paradox”. J Biol Chem. 1997;272(50):312133121 6. 33. Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther. 2008;120(2):157171. 34. Bagdy G, Riba P, Kecskemeti V, Chase D, Juhasz G. Headache-type adverse effects of NO donors: vasodilation and beyond. Br J Pharmacol. 2010;160(1):20-35. 35. Neeb L,Reuter U.Nitric oxide in migraine. CNS Neurol Disord Drug Targets. 2007;6(4):258264.
RkJQdWJsaXNoZXIy MTk4NDMw